10-Q: Nortech Systems Reports Q1 2026 Results, Revenue Up 12.7%

Nortech Systems Inc. reported a 12.7% increase in net sales for the first quarter of 2026, reaching $30.3 million, driven by growth in the Medical Imaging and Aerospace & Defense sectors, while also securing a new credit facility.

Summary

• Nortech Systems Inc. reported net sales of $30.3 million for the first quarter ended March 31, 2026, an increase of 12.7% compared to $26.9 million in the same period of 2025.
• The company experienced a significant increase in gross profit to $4.7 million, with a gross margin of 15.5%, up from $3.1 million and 11.4% in Q1 2025, attributed to improved plant utilization and higher sales on a fixed cost base.
• Operating income turned positive at $47,000 (0.2% of net sales) for Q1 2026, a substantial improvement from an operating loss of $1.6 million (-6.0% of net sales) in Q1 2025.
• Net loss for the quarter was $34,000, or $(0.01) per share, an improvement from a net loss of $1.3 million, or $(0.48) per share, in the prior year's first quarter.
• The company entered into a new Credit and Security Agreement with Associated Bank on March 20, 2026, providing a $15 million revolving credit facility and a $2.2 million term loan, maturing in March 2029.
• Backlog increased significantly, with the 90-day shipment backlog at $31.5 million and total order backlog at $90.8 million as of March 31, 2026, up 17.7% and 32.9% year-over-year, respectively.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a cautiously optimistic report, with significant operational improvements and revenue growth, but still showing a net loss and a high effective tax rate.

Positives

• Net sales increased by 12.7% to $30.3 million in Q1 2026 compared to $26.9 million in Q1 2025.
• Gross profit improved significantly to $4.7 million from $3.1 million in the prior year.
• Gross margin percentage increased to 15.5% from 11.4% due to improved plant utilization and higher sales.
• Operating income shifted from a loss of $1.6 million to a profit of $47,000.
• Net loss narrowed to $34,000 from $1.3 million in the comparable prior-year period.
• Total order backlog grew by 32.9% year-over-year to $90.8 million as of March 31, 2026.
• Secured a new $15 million revolving credit facility and a $2.2 million term loan with Associated Bank, enhancing liquidity and financial flexibility.
• Aerospace and Defense sales saw a substantial increase of 41.2% due to customer approvals for transferred products and facility optimization efficiencies.
• Medical Imaging sales increased by 15.0% driven by higher sales volume to existing customers.
• Cash used in operating activities decreased to $1.6 million from $2.9 million in the prior year.

Negatives

• The company reported a net loss of $34,000 for the quarter.
• Interest expense increased to $256,000 from $214,000, partly due to the write-off of unamortized debt issuance costs.
• Cash used by accounts receivable and contract assets was $1.6 million, compared to $0.4 million in the prior year.
• Cash used by inventory increased to $2.6 million from a cash provided of $0.5 million in the prior year.
• The effective tax rate increased significantly to 84% in Q1 2026 from 28% in Q1 2025.

Risks

• Volatility in the marketplace affecting market supply, demand, or currency exchange rates.
• Sufficiency of existing financing arrangements, anticipated cash flows, and cash on hand to meet working capital, capital expenditures, and debt repayment needs for the next twelve months.
• Supply chain disruption and unreliability.
• Lack of sufficient human resources to produce products.
• Increased competition from within the EMS industry or decisions by OEMs to limit outsourcing.
• Changes in the reliability and efficiency of operating facilities or those of third parties.
• Increases in certain raw material costs such as copper and oil.
• Commodity and energy cost instability.
• Risks related to FDA noncompliance.
• The loss of a major customer.
• General economic, financial, and business conditions affecting financial condition and results of operations.
• Increased or unanticipated costs related to compliance with securities and environmental regulations.
• Disruption of global or local information management systems due to natural disaster or cyber-security incident.
• Outbreaks of epidemic, pandemic, or contagious diseases affecting operations, customers, or suppliers.

Future Outlook

The company believes its existing financing arrangements, anticipated cash flows from operations, and cash on hand will be sufficient to satisfy its working capital needs, capital expenditures, and debt repayments for the next year. The company is also focused on expanding and diversifying its customer base and improving competitiveness through strategic investments and global footprint expansion.

Management Comments

• Net sales for the three months ended March 31, 2026 were positively impacted in Aerospace and Defense from the receipt of customer approvals for products transferred from our Blue Earth facility to our Bemidji facility during 2025 as well as manufacturing and plant utilization efficiencies gained related to our 2025 facility optimization.
• The increase in gross margin percentage was the result of improved plant utilization primarily from our restructuring activities and higher sales on a fixed cost base.
• General and administrative expenses, as measured as a percentage of net sales, were 9.9% and 10.8% for the three months ended March 31, 2026 and 2025, respectively. This decrease as a percentage of net sales was primarily the result of higher sales on a fixed cost base.
• The improvement in operating income was primarily driven by higher gross margin percentage, which increased operating income by $1,234, and higher net sales, which contributed an additional $390.

Industry Context

StockSavvy.ai notes that Nortech Systems' performance in Q1 2026 reflects a positive trend in the EMS contract manufacturing sector, particularly within specialized markets like medical devices and aerospace. The company's ability to increase sales and improve margins, despite a net loss, indicates operational improvements and strategic execution in a competitive landscape.

Comparison to Industry Standards

• Nortech's gross margin of 15.5% in Q1 2026 is an improvement from 11.4% in Q1 2025. While specific industry benchmarks for EMS contract manufacturers can vary widely based on specialization and scale, this improvement suggests better operational efficiency compared to its own historical performance.
• The company's focus on medical-related markets, which account for over 50% of net sales, aligns with a strong growth segment within the broader manufacturing industry. Competitors in this space, such as Jabil Circuit or Plexus Corp., also emphasize medical device manufacturing, indicating a competitive but growing market.
• The increase in backlog, particularly in Aerospace and Defense, suggests a positive demand environment for specialized manufacturing services, a trend observed across many industrial and defense contractors globally.

Legal Proceedings

• The company is subject to various legal proceedings and claims that arise in the ordinary course of business.

Stakeholder Impact

• Shareholders: Improved financial performance with increased sales and narrowed net loss, along with new financing, may be viewed positively. However, the continued net loss and high effective tax rate could be concerns.
• Employees: The company incurred restructuring charges and staff reductions in Q1 2025, but Q1 2026 shows positive operational trends which could lead to increased stability. The approval of the 2026 Equity Incentive Plan may benefit key employees.
• Customers: Increased sales and backlog suggest continued demand for Nortech's services. The company's focus on quality and on-time delivery is crucial for maintaining customer relationships.
• Creditors: The new financing arrangement with Associated Bank provides a more robust credit structure, potentially improving confidence for creditors.

Next Steps

• Shareholder approval for the 2026 Equity Incentive Plan at the upcoming annual meeting in May 2026.
• Continued focus on lean manufacturing initiatives, quality, and on-time delivery improvements.
• Expansion and diversification of customer base.
• Strategic investments to capitalize on growth opportunities in medical markets and improve global competitiveness.
• Focus on improving asset utilization and profitability in industrial and defense markets.
• Evaluation of the potential impact of new tariff actions on future material costs and sourcing decisions.

Key Dates

Recommendation

The company shows significant operational improvements with revenue growth and margin expansion, leading to a positive operating income. However, the continued net loss, high effective tax rate, and reliance on financing arrangements suggest caution. While the trend is positive, further sustained profitability and a clearer path to consistent earnings are needed for a stronger recommendation.

Keywords

Nortech Systems, Form 10-Q, Quarterly Report, Contract Manufacturing, EMS, Medical Device, Medical Imaging, Aerospace and Defense, Industrial Markets, Net Sales, Gross Profit, Operating Income, Net Loss, Backlog, Financing Arrangement, Associated Bank, Credit Facility, Term Loan, Financial Statements